Transforming growth factor-beta 1 increases cell migration and beta 1 integrin up-regulation in human lung cancer cells

Graduate Institute of Chinese Medical Science, China Medical University, Taichung, Taiwan.
Lung Cancer (Impact Factor: 3.74). 10/2008; 64(1):13-21. DOI: 10.1016/j.lungcan.2008.07.010
Source: PubMed

ABSTRACT Transforming growth factor-beta1 (TGF-beta1) plays a crucial role in adhesion and migration of human cancer cells. Besides, integrins are the major adhesive molecules in mammalian cells. Here we found that TGF-beta1 increased the migration and cell surface expression of beta1 integrin in human lung cancer cells (A549 cells). TGF-beta1 stimulation increased phosphorylation of p85alpha subunit of phosphatidylinositol 3-kinase (PI3K) and Ser(473) of Akt was determined. Besides, we performed that PI3K inhibitor (Ly294002) or Akt inhibitor suppressed the TGF-beta1-induced migration activities of A549 cells. Treatment of A549 cells with NF-kappaB inhibitor (PDTC) or IkappaB protease inhibitor (TPCK) also repressed TGF-beta1-induced cells migration and beta1 integrins expression. In addition, treatment of A549 cells with TGF-beta1 induced IkappaB kinase alpha/beta (IKKalpha/beta) phosphorylation, IkappaB phosphorylation, p65 Ser(536) phosphorylation, and kappaB-luciferase activity. Furthermore, the TGF-beta1-mediated increases in IKKalpha/beta, IkappaBalpha phosphorylation and p65 Ser(536) phosphorylation were inhibited by Ly294002 and Akt inhibitor. Co-transfection with p85alpha and Akt mutants also reduced the TGF-beta1-induced kappaB-luciferase activity. Taken together, our results suggest that TGF-beta1 acts through PI3K/Akt, which in turn activates IKKalpha/beta and NF-kappaB, resulting in the activations of beta1 integrins and contributing the migration of human lung cancer cells.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The prostaglandin E2 (PGE2) E prostanoid (EP)1 receptor shown to be associated with lung cancer cell invasion. However, the mechanism of EP1 receptor‑mediated cell migration remains to be elucidated. β1 integrin is an essential regulator of the tumorigenic properties of non‑small‑cell lung carcinoma (NSCLC) cells. To date, little is known regarding the association between the EP1 receptor and β1 integrin expression. The present study investigated the effect of EP1 receptor activation on β1 integrin expression and cell migration in NSCLC cells. A total of 34 patients with clinical diagnosis of NSCLC and 10 patients with benign disease were recruited for the present study. The expression levels of the EP1 receptor and β1 integrin expression were studied in resected lung tissue using immunohistochemistry. A statistical analysis was performed using Stata se12.0 software. The effects of PGE2, EP1 agonist 17‑phenyl trinor‑PGE2 (17‑PT‑PGE2) and the nuclear factor κ‑B (NF‑κB) inhibitor on β1 integrin expression were investigated on A549 cells. The expression of β1 integrin and the phosphorylation of NF‑κB‑p65 Ser536 was investigated by western blot analysis. Cell migration was assessed by a transwell assay. The results demonstrated that β1 integrin and EP1 receptor expression exhibited a positive correlation of evident significance in the 44 samples. The in vitro migration assay revealed that cell migration was increased by 30% when the cells were treated with 5 µM 17‑PT‑PGE2 and that the pre‑treatment of β1 integrin monoclonal antibody inhibited 17‑PT‑PGE2‑mediated cell migration completely. PGE2 and 17‑PT‑PGE2 treatment increased β1 integrin expression. RNA interference against the EP1 receptor blocked the PGE2‑mediated β1 integrin expression in A549 cells. Treatment with 17‑PT‑PGE2 induced NF‑κB activation, and the selective NF‑κB inhibitor pyrrolidinedithiocarbamate inhibited 17‑PT‑PGE2‑mediated β1 integrin expression. In conclusion, the present study indicated that the PGE2 EP1 receptor regulates β1 integrin expression and cell migration in NSCLC cells by activating the NF‑κB signaling pathway. Targeting the PGE2/EP1/β1 integrin signaling pathway may aid in the development of new therapeutic strategies for the prevention and treatment of this type of cancer.
    Molecular Medicine Reports 02/2014; 9(5). DOI:10.3892/mmr.2014.2000 · 1.48 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Phenotype reprogramming during transforming growth factor β (TGFβ)-induced epithelial-mesenchymal transition (EMT) is an extensive and dynamic process, orchestrated by the integration of biological signaling across multiple timescales. As part of the numerous transcriptional changes necessary for EMT, TGFβ-initiated Smad3 signaling results in remodeling of the redox environment and decreased nucleophilic tone. Because Smad3 itself is susceptible to attenuated activity through antioxidants, the possibility of a positive feedback loop exists, albeit the time scales on which these mechanisms operate are quite different. We hypothesized that the decreased nucleophilic tone acquired during EMT promotes Smad3 signaling, enhancing acquisition and stabilization of the mesenchymal phenotype. Previous findings supporting such a mechanism were characterized independent of each other; we sought to investigate these relationships within a singular experimental context. In this study, we characterized multivariate representations of phenotype as they evolved over time, specifically measuring expression of epithelial/mesenchymal differentiation, redox regulators, and Smad transcription factors. In-cell western (ICW) assays were developed to evaluate multivariate phenotype states as they developed during EMT. Principal component analysis (PCA) extracted anti-correlations between phospho-Smad3 (pSmad3) and Smad2/Smad4, which reflected a compensatory up-regulation of Smad2 and Smad4 following cessation of TGFβ signaling. Measuring transcript expression following EMT, we identified down-regulation of numerous antioxidant genes concomitant with up-regulation of NADPH oxidase 4 (NOX4) and multiple mesenchymal phenotype markers. TGFβ treatment increased CM-H2DCF-DA oxidation, decreased H2O2 degradation rates, and increased glutathione redox potential. Our findings suggest that the decreased nucleophilic tone during EMT coincides with the acquisition of a mesenchymal phenotype over too long a time scale to enable enhanced Smad3 phosphorylation during initiation of EMT. We further challenged the mesenchymal phenotype following EMT through antioxidant and TGFβ inhibitor treatments, which failed to induce a mesenchymal-epithelial transition (MET). Our characterization of multivariate phenotype dynamics during EMT indicates that the decrease in nucleophilic tone occurs alongside EMT, however maintenance of the mesenchymal phenotype following EMT is independent of the both the nascent redox state and continuous TGFβ signaling.
    Free Radical Biology and Medicine 07/2014; 76. DOI:10.1016/j.freeradbiomed.2014.07.032 · 5.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nuclear factor (NF)-κB signaling pathway contributes to the pathogenesis of lung fibrosis. However, the expression and roles of NF-κB p65 subunit in fibroblasts under fibrotic condition have not been studied. We checked the expression of p65 in lung tissue and fibroblasts from bleomycin (BLM) challenged mice, and investigated the roles of p65 in human lung fibroblasts differentiation during transforming growth factor β (TGF-β) challenge. A murine model of BLM-induced lung fibrosis and in vitro cultures of lung fibroblast from human and mouse were used to study the expression and role of p65 during fibrogenesis. The si-RNA knockdown strategy was used to check the mechanism of TGF-β induced p65 expression and roles of p65 during fibroblast differentiation. We found that the expression of p65 was significantly increased in lung tissue, fibrotic foci and fibroblast from BLM-challenged mice. In vitro, TGF-β stimulated p65 expression, nuclear translocation and cell differentiation in human lung fibroblast; knockdown smad3 expression inhibited TGF-β-induced p65 expression and differentiation in human lung fibroblast. Additionally, knockdown the expression of p65 suppressed TGF-β-induced differentiation and p65 translocation to nuclei in human lung fibroblast. These data suggested that p65 expression is up-regulated in lung fibroblast during differentiation through TGF-β/smad3 pathway and synergistically regulates TGF-β induced differentiation of lung fibroblasts. Copyright © 2014. Published by Elsevier Inc.
    Life Sciences 12/2014; 122. DOI:10.1016/j.lfs.2014.11.033 · 2.30 Impact Factor